Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1522  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


    Article Cited by others

ORIGINAL ARTICLE

Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis

Soni Maheshkumar P, Shelkar Nilakash, Gaikwad Rajiv V, Vanage Geeta R, Samad Abdul, Devarajan Padma V

Year : 2014| Volume: 6| Issue : 1 | Page no: 22-30

   This article has been cited by
 
1 Mannose-Anchored Nano-Selenium Loaded Nanostructured Lipid Carriers of Etravirine for Delivery to HIV Reservoirs
Satish Rojekar, Leila Fotooh Abadi, Rohan Pai, Mahendra Kumar Prajapati, Smita Kulkarni, Pradeep R. Vavia
AAPS PharmSciTech. 2022; 23(7)
[Pubmed]  [Google Scholar] [DOI]
2 Enhanced Antibacterial Activity of Doxycycline and Rifampicin Combination Loaded in Nanoparticles against Intracellular Brucella abortus
Shilpa Dawre, Padma V. Devarajan, Abdul Samad
Current Drug Delivery. 2022; 19(1): 104
[Pubmed]  [Google Scholar] [DOI]
3 Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility: What can we learn from the literature
Shiqi Guo, Yanan Shi, Yanzi Liang, Lanze Liu, Kaoxiang Sun, Youxin Li
Asian Journal of Pharmaceutical Sciences. 2021; 16(5): 551
[Pubmed]  [Google Scholar] [DOI]
4 Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept
Satish Rojekar, Leila Fotooh Abadi, Rohan Pai, Ketan Mahajan, Smita Kulkarni, Pradeep R Vavia
European Journal of Pharmaceutical Sciences. 2021; 164: 105916
[Pubmed]  [Google Scholar] [DOI]
5 Advances and challenges in nanocarriers and nanomedicines for veterinary application
Suzana Gonçalves Carvalho, Victor Hugo Sousa Araujo, Aline Martins dos Santos, Jonatas Lobato Duarte, Amanda Letícia Polli Silvestre, Bruno Fonseca-Santos, Janaina Cecília Oliveira Villanova, Maria Palmira Daflon Gremião, Marlus Chorilli
International Journal of Pharmaceutics. 2020; 580: 119214
[Pubmed]  [Google Scholar] [DOI]
6 Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis
Aikaterini Lalatsa, Larry Statts, Jéssica Adriana de Jesus, Olivia Adewusi, Maria Auxiliadora Dea-Ayuela, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Domingues Passero, Dolores R. Serrano
International Journal of Pharmaceutics. 2020; 588: 119734
[Pubmed]  [Google Scholar] [DOI]
7 Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis
Joachim Müller,Adriana Aguado-Martínez,Luis-Miguel Ortega-Mora,Javier Moreno-Gonzalo,Ignacio Ferre,Matthew A. Hulverson,Ryan Choi,Molly C. McCloskey,Lynn K. Barrett,Dustin J. Maly,Kayode K. Ojo,Wes Van Voorhis,Andrew Hemphill
Journal of Antimicrobial Chemotherapy. 2017;
[Pubmed]  [Google Scholar] [DOI]
8 Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential
Anil B. Jindal
Drug Delivery and Translational Research. 2016;
[Pubmed]  [Google Scholar] [DOI]
9 Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
Shilpi Khare,Steven L. Roach,S. Whitney Barnes,Dominic Hoepfner,John R. Walker,Arnab K. Chatterjee,R. Jeffrey Neitz,Michelle R. Arkin,Case W. McNamara,Jaime Ballard,Yin Lai,Yue Fu,Valentina Molteni,Vince Yeh,James H. McKerrow,Richard J. Glynne,Frantisek Supek,Margaret A Phillips
PLOS Pathogens. 2015; 11(7): e1005058
[Pubmed]  [Google Scholar] [DOI]
10 In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs
Qaisar Jamal,Nazma Habib Khan,Sobia Wahid,Mahwish Mustafa Awan,Colin Sutherland,Akram Shah
Experimental Parasitology. 2015; 154: 93
[Pubmed]  [Google Scholar] [DOI]
11 Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice
Joachim Müller,Adriana Aguado-Martinez,Vera Manser,Vreni Balmer,Pablo Winzer,Dominic Ritler,Isabel Hostettler,David Arranz-Solís,Luis Ortega-Mora,Andrew Hemphill
International Journal for Parasitology: Drugs and Drug Resistance. 2015; 5(1): 16
[Pubmed]  [Google Scholar] [DOI]
12 Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug
M. Intakhab Alam,Sanjula Baboota,Alka Ahuja,Mushir Ali,Javed Ali,Jasjeet K. Sahni,Aseem Bhatnagar
International Journal of Pharmaceutics. 2014;
[Pubmed]  [Google Scholar] [DOI]
13 Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance
Raman Rohilla,Tarun Garg,Amit K. Goyal,Goutam Rath
Drug Delivery. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article